Updated Jan 2020

Alternative Cancer Treatment  We can advise guide integrate diet vitamin herbal measures. But our alternatives are classic approved drugs classic classic evidence lab and clinic off label complements to (potentiators of ) best standard of care

Our specialized, innovative approach controls difficult to treat cancers when traditional approaches are limited.  Our methodology for cancers that respond poorly or have failed conventional therapy.  We can now New predict resistance and survival odds  

Tumor's  Drug Resistance. We have multiple  proven solutions 

Many tumors are resistant  g to standard chemotherapeutic regimens. They don't stop growing . Even,originally effective drugs fail when tumor's  mutate imaking the drugs  ineffective. , cancers that may have responded well  start to grow again. Our proven specialty is to safely reverse resistance three ways table X progress & report 

  cancerous cells may modify, become drug resistant and then grow. cancer cell may produce hundreds of copies of a certain gene that then produces great quantities of protein that, imake the  drug ineffective.           We knock out the protein production

Te cancer cells may eliminate certain drugs as fast as they enter. In other cases, cancer cells may  stop allowing for the drug to enter, or may actually repair what was destroyed by the drug, our helper drugs make lower doses fully effective 

Creating new options

We integrate peer leader research to reduce and prevent chemotherapeutic drug resistance.and improve on these leads with our laboratory discoveries.   combinations of drugs, address the issue of drug resistance. We developed safer three way in contrast to often ineffective one way combinations

Buckner Oncology is a pioneer lab and clinical research and experience against all types of adenocarcinomas .see SIGO &new GBM sarcoma melanoma 

We safely beat the numbers odds 2-4 fold better than Standard chemotherapeutic treatments which often have a failure rate as high as 50%. We have stage IV reviewed benefit for these primary untreated and resistant high risk cancers..

• Pancreatic cancer
• Biliary tract cancers
• Gastroesophageal cancer
• Colon cancer
• Sarcoma,( Melanoma,reverse resistance to immunotherapy

The benefit is substantial – a much better chance to fight cancers that are stubborn and resistant to traditional therapies with a prognosis of months, not years. We gain years. Many types of patients benefit from the cutting-edge therapy offered by Dr. Bruckner and Bruckner Oncology, including:

• Resistant Patients who have not had success with traditional, standard therapy
• Patients who are unsatisfied with the predicted outcomes of standard therapy
• Patients who can not tolerate standard high dose therapy
• Patients not eligible for clinical trials, such as the elderly over the age of 75 and those with multiple comorbidities (two or more coexisting medical conditions or diseases).   Uniquely   Elderly patients have full survival benefit with our safer regimens
• Patients who are not willing to participate in randomized clinical trials
• Complex Patients ..in need of a second opinion 

Please refer to the latest news and progress report re individual tumor's TheTestimonials section offers perspectives from the patient’s point of view.  Quality of life, safety and a chance to beat,the odds matter